Skip to main content

Merck Recalls Temodar and Temozolomide Bottles with Cracked Caps

  • Temodar® (Temozolomide)
  • Close up view of the Temozolomide Capsules cracked cap rendering the child-resistant closure ineffective
Name of Product:
Bottles with cracked caps containing Temodar® (Temozolomide) and Temozolomide (generic) capsules
Hazard:
The bottle cap can be cracked which can cause the child-resistant closure to become ineffective to young children who can gain unintended access to the capsules, posing a risk of poisoning.
Remedy:
Replace
Recall Date:
August 18, 2015
Units:
About 276,000
Consumer Contact

Merck Information Center at 800-943-8069 from 8 a.m. to 8 p.m. ET Monday through Friday, or visit www.merck.com and click on "Important Temodar Information" for more information.

Recall Details

Description:

This recall to replace involves bottle caps for Temodar and Temozolomide (generic) capsules, an oral chemotherapy drug. The capsules were distributed in 5- and 14-count brown glass bottles that have white plastic child-resistant caps. A white label affixed to the bottle has the word "Temozolomide" printed in black lettering.

Remedy:

Consumers should immediately inspect their bottle caps for cracks. If a crack is found, consumers should contact Merck for a replacement cap. As with all drug products, the bottles should be stored up high, out of sight and reach of young children. Consumers may continue to use the drug as directed.

Incidents/Injuries:

None reported.

Sold At:
Clinics and pharmacies nationwide as a prescribed medicine from July 2013 to August 2015. The container was included in the cost of the medication which is based on quantities prescribed, health insurance terms and other factors.
Manufacturer(s):
Merck Sharp & Dohme Corp., of Whitehouse Station, N.J.
Manufactured In:
United States
Recall number:
15-219

Note: Individual Commissioners may have statements related to this topic. Please visit www.cpsc.gov/commissioners to search for statements related to this or other topics.

If you are experiencing issues with a recall remedy or believe a company is being non-responsive to your remedy request, please use this form and explain the situation to CPSC.

Related Recalls

Recalled Nationwide Pharmaceutical Ferrous Sulfate (Iron) Enteric-Coated Tablets, 324 mg – 100 Tablet Bottles
Nationwide Pharmaceutical Recalls Iron Dietary Supplements Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

The recalled dietary supplements contain iron which must be in child-resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child-resistant, posing a risk of poisoning if the contents are swallowed by young children.

Recalled PhysiciansCare Allergy in 50 caplets (50 packets, 1 caplet each)
Acme United Recalls PhysiciansCare Brand Allergy Relief and Cold and Cough Tablets Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning; Sold on Amazon.com

The recalled products contain diphenhydramine hydrochloride and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

Recalled Nurtec® ODT (rimegepant) orally disintegrating tablets
Pfizer Recalls Nurtec ODT Prescription Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

The recalled prescription drugs must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

Suplemento alimenticio de hierro para mujeres de GNC Women's Iron Complete Dietary Supplement – sesenta (60) cápsulas
Women’s Iron Complete Supplements Recalled by GNC Due to Failure to Meet Child Resistant Closure Requirement; Risk of Poisoning

The dietary supplement blister packaging is not child resistant, as required by federal law. If ingested by a child, these supplements could cause serious injury or death.

Temodar® (Temozolomide)
Merck Recalls Temodar and Temozolomide Bottles with Cracked Caps
The bottle cap can be cracked which can cause the child-resistant closure to become ineffective to young children who can gain unintended access to the capsules, posing a risk of poisoning.
No image available
Vicks Dayquil Cold & Flu Liquicaps Recalled by Procter & Gamble Due To Failure to Meet Child-Resistant Closure Requirement
In cooperation with the U.S. Consumer Product Safety Commission (CPSC), The Procter & Gamble Co., of Cincinnati, Ohio, is voluntarily recalling about 700,000 packages of Vicks Dayquil Cold & Flu 24-Count Bonus Pack Liquicaps. The cold and flu medicine contains acetaminophen and is not in child-resistant packaging and lacks the statement, "This Package for Households Without Young Children," as required by the Poison Prevention Packaging Act. This medicine could cause serious health problems or death to a child if several of the capsules are swallowed.
About the U.S. CPSC

The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than $1 trillion annually. Since the CPSC was established more than 50 years ago, it has worked to ensure the safety of consumer products, which has contributed to a decline in injuries associated with these products.

Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.

For lifesaving information:

Choose Your Recall Emails Get Notified About Each Recall via Email.
Report an unsafe product